More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation. Editorial Article uri icon

Overview

publication date

  • September 1, 2017

Identity

PubMed Central ID

  • PMC5643725

Scopus Document Identifier

  • 85030449050

Digital Object Identifier (DOI)

  • 10.21037/tau.2017.03.22

PubMed ID

  • 29082983

Additional Document Info

volume

  • 6

issue

  • Suppl 4